US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veraxa Biotech Holding AG

1.95

+0.06003.17%

Post-market: 1.950.00000.00%19:02 EDT

Volume:80.15K

Turnover:155.63K

Market Cap:275.75M

PE:9.10

High:2.00

Open:1.86

Low:1.85

Close:1.89

52wk High:27.36

52wk Low:1.70

Shares:141.41M

Float Shares:41.01M

Volume Ratio:0.97

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2142

ROE:-65.29%

ROA:-20.46%

PB:7.11

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Veraxa Biotech Files Form 3 for Interim CFO Carl Von Halem

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies

Veraxa Biotech Holding Ag - Files to Register Resale of up to 25 Mln Ordinary Shares - SEC Filing

THOMSON REUTERS

Veraxa Biotech Files First BiTAC-related Patent Applications for Cancer Therapy Platforms

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/VRXA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.95,"timestamp":1787342400000,"preClose":1.89,"halted":0,"volume":80147,"hourTrading":{"tag":"盘后","latestPrice":1.95,"preClose":1.95,"latestTime":"19:02 EDT","volume":146,"amount":283.17,"timestamp":1787353358074,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03174603174603178,"floatShares":41012504,"shares":141407813,"eps":0.2142,"marketStatus":"Market Closed","change":0.06,"latestTime":"08-21 16:00:00 EDT","open":1.86,"high":2,"low":1.8501,"amount":155628,"amplitude":0.079312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.89,"preHourTrading":{"tag":"盘前","latestPrice":1.87,"preClose":1.89,"latestTime":"09:27 EDT","volume":304,"amount":569.2840192,"timestamp":1787318870054,"change":-0.02,"changeRate":-0.010582,"amplitude":0.015873},"postHourTrading":{"tag":"盘后","latestPrice":1.95,"preClose":1.95,"latestTime":"19:02 EDT","volume":146,"amount":283.17,"timestamp":1787353358074,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.967295187072036},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":41012504,"roa":"-20.46%","roe":"-65.29%","lyrEps":0,"volumeRatio":0.967295187072036,"shares":141407813,"dividePrice":0,"high":2,"amplitude":0.079312,"preClose":1.89,"low":1.8501,"week52Low":1.7,"pbRate":"7.11","week52High":27.36,"institutionHeld":0,"latestPrice":1.95,"eps":0.2142,"divideRate":0,"volume":80147,"delay":0,"ttmEps":0.2142,"open":1.86,"prevYearClose":18.65,"prevWeekClose":1.87,"prevMonthClose":1.76,"prevQuarterClose":1.88,"fiveDayClose":1.87,"twentyDayClose":1.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-08-21","current":9.103641,"percent":0,"low":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"high":-1.331869,"avg":-1.34261,"sd":0.010741,"marketCap":47660725},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725}],"updateTime":1787491821640},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRXA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661234428","title":"Veraxa Biotech Files Form 3 for Interim CFO Carl Von Halem","url":"https://stock-news.laohu8.com/highlight/detail?id=2661234428","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661234428?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:00","pubTimestamp":1787256059,"startTime":"0","endTime":"0","summary":"Veraxa Biotech files Form 3 for Interim CFO Carl von HalemInterim CFO Carl von Halem filed an initial Form 3 for Veraxa Biotech AG, dated July 10, 2026.Disclaimer:This news brief was created by Public","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL7C4F43:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656766","title":"VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656766","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656766?lang=en_us&edition=fundamental","pubTime":"2026-08-07 01:00","pubTimestamp":1786035614,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 6th, 2026, FinanceWire The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC&r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-while-expanding-patent-portfolio-for-next-generation-antibody-technologies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-while-expanding-patent-portfolio-for-next-generation-antibody-technologies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QQQM","QQQA","QQQJ","VRXA","BK4585","SQQQ","GPIQ","JEPQ","XBI","QDTE","ONEQ","QQQ","TQQQ","QYLG","QQQY","NVIW.SI","TQQY","BK4581","IYW",".IXIC","QID","FTEC","BK4588","QQQE","TECS","NDX","MNQmain","NQmain","QLD","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656917923","title":"Veraxa Biotech Holding Ag - Files to Register Resale of up to 25 Mln Ordinary Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2656917923","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656917923?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:14","pubTimestamp":1785532463,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X2AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656399655","title":"Veraxa Biotech Files First BiTAC-related Patent Applications for Cancer Therapy Platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=2656399655","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656399655?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:06","pubTimestamp":1785528362,"startTime":"0","endTime":"0","summary":"Veraxa Biotech files first BiTAC-related patent applications for cancer therapy platformsVeraxa Biotech filed its first BiTAC-related patent applications in H1 2026 covering composition of matter for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL5xBfbf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":16,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VRXA\",params:#limit:6,delay:false,,,undefined,":[]}}